this is index.php

Respiratory Syncytial Virus (RSV) Prevention study group, Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Publication date: 10/23/2015

Authors: O'Brien KL, Chandran A, Weatherholtz R, Jafri HS, Griffin MP, Bellamy T, Millar EV, Jensen KM, Harris BS, Reid R, Moulton LH, Losonsky GA, Karron RA, Santosham M

Publication: Lancet Infect Disease

Focus Area: Infectious Disease Prevention

Respiratory Syncytial Virus vaccination during pregnancy and effects in infants

Publication date: 07/30/2020

Authors: Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, Swamy GK, Agrawal S, Ahmed K, August A, Baqui AH, Calvert A, Chen J, Cho I, Cotton MF, Cutland CL, Englund JA, Fix A, Gonik B, Hammitt L, Heath PT, de Jesus JN, Jones CE, Khalil A, Kimberlin DW, Libster R, Llapur CJ, Lucero M, Pérez Marc G, Marshall HS, Masenya MS, Martinón-Torres F, Meece JK, Nolan TM, Osman A, Perrett KP, Plested JS, Richmond PC, Snape MD, Shakib JH, Shinde V, Stoney T, Thomas DN, Tita AT, Varner MW, Vatish M, Vrbicky K, Wen J, Zaman K, Zar HJ, Glenn GM, Fries LF. Prepare Study Group

Publication: N Engl J Med

Focus Area: Infectious Disease Prevention

Risk factors for invasive pneumococcal disease among Navajo adults.

Publication date: 01/01/2007

Authors: Watt JP, O’Brien KL, Benin AL, McCoy SI, Donaldson CM, Reid R, Schuchat A, Zell ER, Hochman M, Santosham M, Whitney CG.

Publication: Am J Epidemiol

Focus Area: Infectious Disease Prevention